Medicare and Medicaid
Featured Topics
Lead story
Other featured articles
-
Comments to Representatives DeGette and Bucshon on Building on the Successes of 21st Century Cures
Schaeffer Center experts provided comments to lawmakers on additional measures for enhancing or improving the effectiveness of the 21st Century Cures Act.
Posted in -
Growing Divergence Between Medicare Advantage Plan Bids and Payments to Plans
While risk-adjusted Medicare Advantage bids have decreased compared with risk-adjusted traditional Medicare spending, total payments to MA plans have risen partly because of the growing impact of payment adjustments.
Posted in -
Study: Exploding Popularity of Ozempic and Wegovy Among Privately Insured Patients May Worsen Disparities
Publicly insured individuals who are most likely to benefit from new diabetes and obesity drugs are less likely to get them than those with private insurance.
Posted in -
Comments to CMS on Transcatheter Tricuspid Valve Replacement (TTVR) and Broader CED Policy Considerations
Schaeffer Center experts provided comments to CMS on issues with how Coverage with Evidence Determination policy is applied.
Posted in
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.
Our Experts On Medicare and Medicaid
Our Work In Medicare and Medicaid
-
Estimating Overpayments to MA Plans: MedPAC Critics Get It Wrong
Why many of the key assertions in a recent Forefront article challenging the MedPAC’s estimate that favorable selection and upcoding increase payments to Medicare Advantage (MA) plans in 2024 by $83 billion are wrong
Categorized in -
Access to New Alzheimer’s Treatments Bogged Down by Medicare Policy
There are now two Alzheimer’s treatments with significant clinical benefit. It’s not clear how quickly patients will be able to benefit.
Categorized in -
Fixing Medicare Advantage With Competitive Bidding
Schaeffer experts recommend using competitive bidding for standardized benefits to set plan payments and enhance beneficiary choice in Medicare Advantage.
Categorized in -
Analysis: Competitive Bidding Vital to Ensuring Sustainability of Medicare Advantage
Schaeffer Center researchers detail how a competitive bidding structure – whereby plans compete on price and quality – would improve the MA program.
Categorized in -
Shingles Vaccination in Medicare Part D After Inflation Reduction Act Elimination of Cost Sharing
Unlike commercially insured individuals who have no cost sharing for recommended vaccinations, in 2021, Medicare beneficiaries receiving vaccines covered under Medicare Part D paid $234 million out of pocket (OOP), with a mean OOP cost of $76.94 for shingles vaccines.
Categorized in -
Study: Shingles Vaccine Uptake Dramatically Increased After Inflation Reduction Act Removes Patient Out-of-Pocket Cost
Researchers from USC and University of Michigan say the study adds to “robust evidence” that eliminating costs helps patients access preventive services
Categorized in